Midkine-deficiency increases the anabolic response of cortical bone to mechanical loading

Bone

Volumn 48, Issue 4, 2011, Pages 945-951

  Liedert, Astrid ^a   Mattausch, Laura ^a   Röntgen, Viktoria ^a   Blakytny, Robert ^a   Vogele, Daniel ^a   Pahl, Marcus ^a   Bindl, Ronny ^a   Neunaber, Claudia ^b   Schinke, Thorsten ^b   Harroch, Sheila ^c   Amling, Michael ^b   Ignatius, Anita ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c INSTITUT PASTEUR   (France)

Author keywords

Mechanical loading; Midkine; Wnt signaling

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MIDKINE; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE ZETA; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 6; WNT3A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MINERALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; CORTICAL BONE; FEMALE; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PERIOSTEUM; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ULNA; WEIGHT BEARING; WILD TYPE;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; BONE AND BONES; CELLS, CULTURED; CYTOKINES; DNA PRIMERS; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 79952695464     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.12.019     Document Type: Article

References (40)

1. Rubin J., Rubin C., Jacobs C.R. Molecular pathways mediating mechanical signaling in bone. Gene 2006, 367:1-16.
2. Robling A.G., Castillo A.B., Turner C.H. Biomechanical and molecular regulation of bone remodeling. Annu. Rev. Biomed. Eng. 2006, 8:455-498.
3. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J. Biochem. (Tokyo). 2002, 132:359-371.
4. Ohta S., Muramatsu H., Senda T., Zou K., Iwata H., Muramatsu T. Midkine is expressed during repair of bone fracture and promotes chondrogenesis. J. Bone Miner. Res. 1999, 14:1132-1144.
5. Petersen W., Wildemann B., Pufe T., Raschke M., Schmidmaier G. The angiogenic peptide pleiotrophin (PTN/HB-GAM) is expressed in fracture healing: an immunohistochemical study in rats. Arch. Orthop. Trauma. Surg. 2004, 124:603-607.
6. Nakamura E., Kadomatsu K., Yuasa S., Muramatsu H., Mamiya T., Nabeshima T., et al. Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour. Genes Cells 1998, 3:811-822.
7. Amet L.E., Lauri S.E., Hienola A., Croll S.D., Lu Y., Levorse J.M., et al. Enhanced hippocampal long-term potentiation in mice lacking heparin-binding growth-associated molecule. Mol. Cell. Neurosci. 2001, 17:1014-1024.
8. Imai S., Heino T.J., Hienola A., Kurata K., Buki K., Matsusue Y., et al. Osteocyte-derived HB-GAM (pleiotrophin) is associated with bone formation and mechanical loading. Bone 2009, 44:785-794.
9. Neunaber C., Catala-Lehnen P., Beil F.T., Marshall R.P., Kanbach V., Baranowsky A., et al. Increased trabecular bone formation in mice lacking the growth factor midkine. J. Bone Miner. Res. 2010, 25:1724-1735.
10. Sakaguchi N., Muramatsu H., Ichihara-Tanaka K., Maeda N., Noda M., Yamamoto T., et al. Receptor-type protein tyrosine phosphatase zeta as a component of the signaling receptor complex for midkine-dependent survival of embryonic neurons. Neurosci. Res. 2003, 45:219-224.
11. Muramatsu H., Zou P., Suzuki H., Oda Y., Chen G.Y., Sakaguchi N., et al. alpha4beta1- and alpha6beta1-integrins are functional receptors for midkine, a heparin-binding growth factor. J. Cell Sci. 2004, 117:5405-5415.
12. Mbalaviele G., Shin C.S., Civitelli R. Cell-cell adhesion and signaling through cadherins: connecting bone cells in their microenvironment. J. Bone Miner. Res. 2006, 21:1821-1827.
13. Piedra J., Miravet S., Castano J., Palmer H.G., Heisterkamp N., Garcia de Herreros A., et al. p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction. Mol. Cell. Biol. 2003, 23:2287-2297.
14. Nelson W.J., Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
15. Schiller K.R., Mauro L.J. Tyrosine phosphatases as regulators of skeletal development and metabolism. J. Cell. Biochem. 2005, 96:262-277.
16. Meng K., Rodriguez-Pena A., Dimitrov T., Chen W., Yamin M., Noda M., et al. Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc. Natl Acad. Sci. USA 2000, 97:2603-2608.
17. Staal F.J., Weerkamp F., Baert M.R., van den Burg C.M., van Noort M., de Haas E.F., et al. Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion. J. Immunol. 2004, 172:1099-1108.
18. Katoh M. WNT signaling pathway and stem cell signaling network. Clin. Cancer Res. 2007, 13:4042-4045.
19. Rodan G.A., Noda M. Gene expression in osteoblastic cells. Crit. Rev. Eukaryot. Gene Expr. 1991, 1:85-98.
20. Lee K.C., Maxwell A., Lanyon L.E. Validation of a technique for studying functional adaptation of the mouse ulna in response to mechanical loading. Bone 2002, 31:407-412.
21. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 1987, 2:595-610.
22. Kaspar D., Seidl W., Neidlinger-Wilke C., Ignatius A., Claes L. Dynamic cell stretching increases human osteoblast proliferation and CICP synthesis but decreases osteocalcin synthesis and alkaline phosphatase activity. J. Biomech. 2000, 33:45-51.
23. Schinke T., Gebauer M., Schilling A.F., Lamprianou S., Priemel M., Mueldner C., et al. The protein tyrosine phosphatase Rptpzeta is expressed in differentiated osteoblasts and affects bone formation in mice. Bone 2008, 42:524-534.
24. Maeda N., Ichihara-Tanaka K., Kimura T., Kadomatsu K., Muramatsu T., Noda M. A receptor-like protein-tyrosine phosphatase PTPzeta/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta. J. Biol. Chem. 1999, 274:12474-12479.
25. Maeda N., Nishiwaki T., Shintani T., Hamanaka H., Noda M. 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase zeta/RPTPbeta, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM). J. Biol. Chem. 1996, 271:21446-21452.
26. Levy J.B., Canoll P.D., Silvennoinen O., Barnea G., Morse B., Honegger A.M., et al. The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system. J. Biol. Chem. 1993, 268:10573-10581.
27. Stone R.L., Dixon J.E. Protein-tyrosine phosphatases. J. Biol. Chem. 1994, 269:31323-31326.
28. Lau K.H., Baylink D.J. Phosphotyrosyl protein phosphatases: potential regulators of cell proliferation and differentiation. Crit. Rev. Oncog. 1993, 4:451-471.
29. Li R., Morris S.W. Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy. Med. Res. Rev. 2008, 28:372-412.
30. Maehara H., Kaname T., Yanagi K., Hanzawa H., Owan I., Kinjou T., et al. Midkine as a novel target for antibody therapy in osteosarcoma. Biochem. Biophys. Res. Commun. 2007, 358:757-762.
31. Stoica G.E., Kuo A., Powers C., Bowden E.T., Sale E.B., Riegel A.T., et al. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J. Biol. Chem. 2002, 277:35990-35998.
32. Nakanishi T., Kadomatsu K., Okamoto T., Ichihara-Tanaka K., Kojima T., Saito H., et al. Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine. J. Biochem. 1997, 121:197-205.
33. Muramatsu H., Zou K., Sakaguchi N., Ikematsu S., Sakuma S., Muramatsu T. LDL receptor-related protein as a component of the midkine receptor. Biochem. Biophys. Res. Commun. 2000, 270:936-941.
34. Whyte M.P. Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann. NY Acad. Sci. 2010, 1192:190-200.
35. van der Horst G., van der Werf S.M., Farih-Sips H., van Bezooijen R.L., Lowik C.W., Karperien M. Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. J. Bone Miner. Res. 2005, 20:1867-1877.
36. Kahler R.A., Galindo M., Lian J., Stein G.S., van Wijnen A.J., Westendorf J.J. Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. J. Cell. Biochem. 2006, 97:969-983.
37. Muramatsu H., Zou P., Kurosawa N., Ichihara-Tanaka K., Maruyama K., Inoh K., et al. Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors. Genes Cells 2006, 11:1405-1417.
38. Robinson J.A., Chatterjee-Kishore M., Yaworsky P.J., Cullen D.M., Zhao W., Li C., et al. Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J. Biol. Chem. 2006, 281:31720-31728.
39. Armstrong V.J., Muzylak M., Sunters A., Zaman G., Saxon L.K., Price J.S., et al. Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha. J. Biol. Chem. 2007, 282:20715-20727.
40. Yan H.X., Yang W., Zhang R., Chen L., Tang L., Zhai B., et al. Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion. J. Biol. Chem. 2006, 281:15423-15433.